222 related articles for article (PubMed ID: 824163)
1. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
Loubatières AL; Loubatieres-Mariani MM; Alric R; Ribes G; Sorial G; Tarasco A
Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163
[TBL] [Abstract][Full Text] [Related]
2. Glipizide: experimental study and comparison with other sulfonylureas.
Loubatieres-Mariani MM
Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761
[No Abstract] [Full Text] [Related]
3. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
4. [Kinetic aspects of the glipizide-induced hypoglycemia in the dog (author's transl)].
Blayac JP; Ribes G; Valette JF; Loubatières-Mariani MM
J Pharmacol; 1980; 11(4):463-72. PubMed ID: 7206734
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
Gotfredsen CF
Diabetologia; 1976 Aug; 12(4):339-42. PubMed ID: 134920
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
7. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect.
Jorgensen KD
Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791
[TBL] [Abstract][Full Text] [Related]
8. [Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide].
Hausmann L; Schumann G; Kaffarnik H
Arzneimittelforschung; 1978; 28(1):83-6. PubMed ID: 415745
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of hypoglycemic sulfonamides: Ozidia, a new concept].
Selam JL
Diabetes Metab; 1997 Nov; 23 Suppl 4():39-43. PubMed ID: 9463023
[TBL] [Abstract][Full Text] [Related]
10. [Studies on new sulfonylurea derivatives and their metabolites in isolated Langerhans's islets of the rat pancreas (author's transl].
Krause U; Puchinger H; Wacker A
Arzneimittelforschung; 1975 Aug; 25(8):1231-3. PubMed ID: 810148
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of transglutaminase by hypoglycaemic sulphonylureas in pancreatic islets and its possible relevance to insulin release.
Gomis R; Mathias PC; Lebrun P; Malaisse-Lagae F; Sener A; Malaisse WJ
Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):331-49. PubMed ID: 6151221
[TBL] [Abstract][Full Text] [Related]
12. Special pharmacology of the new sulfonylurea glimepiride.
Geisen K
Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
[TBL] [Abstract][Full Text] [Related]
13. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW
Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348
[TBL] [Abstract][Full Text] [Related]
14. Gliflumide, a new oral antidiabetic of high potency and efficacy.
Blumenbach L; Gerhards E; Gutsche H; Klein W; Loge O; Losert W; Schillinger E; Speck U; Vetter H; Wendt H
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):141-51. PubMed ID: 809367
[TBL] [Abstract][Full Text] [Related]
15. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.
Joost HG; Hasselblatt A
Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):185-8. PubMed ID: 112482
[TBL] [Abstract][Full Text] [Related]
16. Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells.
Zünkler BJ; Lenzen S; Männer K; Panten U; Trube G
Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):225-30. PubMed ID: 2452991
[TBL] [Abstract][Full Text] [Related]
17. Effects of glipizide on the insulin production by isolated mouse pancreatic islets.
Andersson A; Borg LA
Acta Endocrinol Suppl (Copenh); 1980; 239():37-41. PubMed ID: 7001842
[TBL] [Abstract][Full Text] [Related]
18. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. II. Pancreatic vein immunoreactive insulin in dogs (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):685-92. PubMed ID: 1237422
[TBL] [Abstract][Full Text] [Related]
19. Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.
Müller G; Satoh Y; Geisen K
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S115-37. PubMed ID: 8529504
[TBL] [Abstract][Full Text] [Related]
20. [The role of cyclic AMP in the control of insulin secretion (author's transl)].
Cerasi E; Grill V
MMW Munch Med Wochenschr; 1977 Sep; 119(38):1229-36. PubMed ID: 198651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
